產品詳情
簡單介紹：
Anti-HPV16 L2抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-HPV16 L2抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-HPV16 L2
Cat. Number:
Anti-HPV16 L2抗體KL-8547R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Human papillomaviruses, particularly type 16 (designated HPV16), infect the genital tract and may lead to cervical cancer. Protection against HPV16 is thought to be provided by neutralizing antibodies directed to the major Anti-HPV16 L2抗體caspid protein L1 of HPV16. HPV16 L1 forms the pentameric assembly unit of the viral shell, and the binding of HPV16 L1 to the cell surface without the involvement of minor capsid protein L2 is believed to be the first step of HPV16 infection. The L1-binding domain located near the C-terminus of L2 binds L1 prior to completion of capsid assembly and is required for efficient encapsidation of the viral genome. In addition, the C-terminus of L1 is necessary for both DNA binding and DNA packaging. Expression of the late gene L1 is restricted to the upper layers of the infected epithelium. HPV16 L1 is able to package unrelated plasmid DNA in vitro and deliver the foreign DNA to eukaryotic cells with the subsequent expression of the encoded gene. L1 shows a diffuse nuclear distribution whereas L2 is localized to punctate nuclear regions identified as promonocytic leukemia protein oncogenic domains (PODs). Coexpression of L1 and L2 induces a relocalization of L1 into the PODs.
Also known as:
HPV16 L2; HPV16-L2; HPV-16; HPV-16 Anti-HPV16 L2抗體capsid; HPV16 capsid protein; HPV16 major capsid protein L2; Human papillomavirus type 16 L2; Human papillomavirus type 16 major capsid protein L2; Major capsid L2 protein; Major capsid protein; Major capsid protein L2; VL2_HPV16.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: HPV16.
●
Immunogen: KLH conjugated synthetic peptide derived from HPV16 L2.
●
Predicted Molecular Weight: 52kDa.Anti-HPV16 L2抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-HPV16 L2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-HPV16 L2抗體
Optimal working dilutions must be determined by the end user.
kl034Mu01 成纖維細胞生長因子4(FGF4)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
kl034Ra01 成纖維細胞生長因子4(FGF4)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
kl035Fi01 成纖維細胞生長因子6(FGF6)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 6 (FGF6)
kl035Hu01 成纖維細胞生長因子6(FGF6)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 6 (FGF6)
kl035Mu01 成纖維細胞生長因子6(FGF6)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 6 (FGF6)
kl035Ra01 成纖維細胞生長因子6(FGF6)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 6 (FGF6)
kl036Ga01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl036Hu01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl036Mu01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl036Po01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl036Ra01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl038Hu01 FMS樣酪氨酸激酶3配體(Flt3L)多克隆抗體 Polyclonal Antibody to FMS Like Tyrosine Kinase 3 Ligand (Flt3L)
kl038Mu01 FMS樣酪氨酸激酶3配體(Flt3L)多克隆抗體 Polyclonal Antibody to FMS Like Tyrosine Kinase 3 Ligand (Flt3L)
kl039Hu01 FMS樣酪氨酸激酶3(Flt3)多克隆抗體 Polyclonal Antibody to FMS Like Tyrosine Kinase 3 (Flt3)
kl040Hu01 趨化因子C-X3-C-基元配體1(CX3CL1)多克隆抗體 Polyclonal Antibody to Chemokine C-X3-C-Motif Ligand 1 (CX3CL1)
kl040Mu01 趨化因子C-X3-C-基元配體1(CX3CL1)多克隆抗體 Polyclonal Antibody to Chemokine C-X3-C-Motif Ligand 1 (CX3CL1)
